Oncotarget

Research Papers:

Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors

Yihsuan S. Tsai _, Daniel Dominguez, Shawn M. Gomez and Zefeng Wang

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:6825-6839. https://doi.org/10.18632/oncotarget.3145

Metrics: PDF 2158 views  |   HTML 1893 views  |   ?  


Abstract

Yihsuan S. Tsai1, Daniel Dominguez2, Shawn M. Gomez1,2,3,4, Zefeng Wang1,2

1Curriculum in Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC 27599, USA

2Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA

3Computer Science, University of North Carolina, Chapel Hill, NC 27599, USA

4Joint Department of Biomedical Engineering at UNC-Chapel Hill and NC State University, Chapel Hill, NC 27599, USA

Correspondence to:

Shawn M. Gomez, e-mail: smgomez@unc.edu

Zefeng Wang, e-mail: zefeng@med.unc.edu

Keywords: Alternative splicing, Cancer classification, RNA processing, Cell cycle

Received: December 02, 2014     Accepted: January 12, 2015     Published: February 05, 2015

ABSTRACT

Dysregulation of alternative splicing (AS) is one of the molecular hallmarks of cancer, with splicing alteration of numerous genes in cancer patients. However, studying splicing mis-regulation in cancer is complicated by the large noise generated from tissue-specific splicing. To obtain a global picture of cancer-specific splicing, we analyzed transcriptome sequencing data from 1149 patients in The Cancer Genome Atlas project, producing a core set of AS events significantly altered across multiple cancer types. These cancer-specific AS events are highly conserved, are more likely to maintain protein reading frame, and mainly function in cell cycle, cell adhesion/migration, and insulin signaling pathways. Furthermore, these events can serve as new molecular biomarkers to distinguish cancer from normal tissues, to separate cancer subtypes, and to predict patient survival. We also found that most genes whose expression is closely associated with cancer-specific splicing are key regulators of the cell cycle. This study uncovers a common set of cancer-specific AS events altered across multiple cancers, providing mechanistic insight into how splicing is mis-regulated in cancers.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3145